R Squared Ltd Takes $165,000 Position in Colgate-Palmolive (NYSE:CL)

R Squared Ltd acquired a new position in Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,810 shares of the company’s stock, valued at approximately $165,000.

A number of other institutional investors have also recently bought and sold shares of CL. Perigon Wealth Management LLC grew its holdings in shares of Colgate-Palmolive by 3.6% during the 4th quarter. Perigon Wealth Management LLC now owns 33,677 shares of the company’s stock valued at $2,982,000 after acquiring an additional 1,184 shares in the last quarter. VCI Wealth Management LLC boosted its position in Colgate-Palmolive by 46.9% during the fourth quarter. VCI Wealth Management LLC now owns 17,547 shares of the company’s stock valued at $1,595,000 after purchasing an additional 5,599 shares during the last quarter. Curbstone Financial Management Corp grew its stake in Colgate-Palmolive by 23.2% in the fourth quarter. Curbstone Financial Management Corp now owns 16,990 shares of the company’s stock valued at $1,545,000 after purchasing an additional 3,200 shares in the last quarter. Griffin Asset Management Inc. increased its position in Colgate-Palmolive by 2.4% in the 4th quarter. Griffin Asset Management Inc. now owns 17,421 shares of the company’s stock worth $1,584,000 after purchasing an additional 405 shares during the last quarter. Finally, IRON Financial LLC raised its stake in shares of Colgate-Palmolive by 3.3% during the 4th quarter. IRON Financial LLC now owns 9,366 shares of the company’s stock worth $851,000 after purchasing an additional 299 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Down 0.2 %

Shares of NYSE CL opened at $89.65 on Thursday. Colgate-Palmolive has a 12-month low of $82.68 and a 12-month high of $109.30. The firm’s 50-day simple moving average is $91.67 and its 200 day simple moving average is $97.34. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company has a market cap of $73.24 billion, a price-to-earnings ratio of 25.69, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Analyst Ratings Changes

Several equities research analysts recently commented on CL shares. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. TD Cowen dropped their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Stifel Nicolaus reduced their price objective on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday, January 17th. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $102.00.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.